Categories: News

Equicare Health releases latest version of their product, Equicare CS 4.10

VANCOUVER, April 9, 2019 /PRNewswire/ – Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, officially released the latest version of their product, Equicare CS (ECS) 4.10.

ECS 4.10 adds a number of new features that make it easier to collect and monitor Patient Reported Outcomes as part of standard clinical practice. The release also includes patient navigation workflow improvements, and GDPR support for our customers in the European Union,” says Malcolm Wright, VP of Product Management at Equicare Health.

The new release includes a feature to automatically assign questionnaires to patients based on compliance goals and clinical need.  We’ve also added a new kiosk that allows patients to complete forms and questionnaires using a tablet in the waiting room.

For more information on our new release or to get an upgrade, please contact Equicare

About Equicare Health
Equicare Health is the industry’s leading provider of comprehensive care coordination solutions. Equicare’s flagship solution EQUICARE CS™ (ECS) is a Multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a number of other clinical tools, i.e. MDT, Clinical trials, a suite of educational material, etc.. In additional to the clinical toolset, Equicare offers an administrative suite of worklists and reports for managing adherence to accreditation standards including Meaningful Use, Commission on Cancer (CoC), NAPBC, QOPI, OCM, etc… ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. www.equicarehealth.com

View original content:http://www.prnewswire.com/news-releases/equicare-health-releases-latest-version-of-their-product-equicare-cs-4-10–300826529.html

SOURCE Equicare Health Inc.

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

30 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

31 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

35 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

35 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

35 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

35 minutes ago